As seen in Figure 6, using total MEK1/2 and ERK1/2 proteins as control, sulindac treatment exhibited a significant reduction of phosphorylation of MEK1/2 and ERK1/2 proteins comparing with caerulein induced chronic pancreatitis mice. The gene discussed is MAP2K1; the disease is chronic pancreatitis.